Literature DB >> 10998679

Opioid and Nonopioid Therapy in Cancer Pain: The Traditional and the New.

.   

Abstract

Management of cancer pain has made sidnificant progress in recent years, partly due to the Agency for Health Care Policy and Research (AHCPR) guidelines, but mostly it seems to be due to the death and dying movement in the world. However, cancer pain on occasion poses significant problems and needs accurate diganosis and appropriate intervention. Pharmacotherapy remains the mainstay of treating cancer pain. Most cancer pain syndromes present with moderate to severe pain, associated with several comorbid problems necessitating the multidisciplinary approach to optimally treat it. The psychologic factors associated wth serious illness, terminal prognoses, and dying complicate the scenario even more as compared with that of nonmalignant pain. Although such patients are entitled to more aggressive analgesic therapy, it is unfortunate that this is not achieved in a significant percentage of cases. In this review, we address some of the above issues and attempt to summarize the traditional pharmacologic therapies highlighting their modern modes of implementation in cancer pain management. Special emphasis on the state-of-the art innovations in this field wil be noted.

Entities:  

Year:  1999        PMID: 10998679     DOI: 10.1007/s11916-999-0018-9

Source DB:  PubMed          Journal:  Curr Rev Pain        ISSN: 1069-5850


  31 in total

Review 1.  Nonopioid and opioid analgesic pharmacotherapy of cancer pain.

Authors:  N I Cherny; K M Foley
Journal:  Hematol Oncol Clin North Am       Date:  1996-02       Impact factor: 3.722

2.  Cancer pain management: pilot implementation of the AHCPR guideline in Utah.

Authors:  J B Rischer; S B Childress
Journal:  Jt Comm J Qual Improv       Date:  1996-10

3.  Capsules and suppositories of methadone for patients on high-dose opioids for cancer pain: clinical and economic considerations.

Authors:  S Watanabe; M Belzile; N Kuehn; J Hanson; E Bruera
Journal:  Cancer Treat Rev       Date:  1996-01       Impact factor: 12.111

4.  Practice guidelines for cancer pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management, Cancer Pain Section.

Authors: 
Journal:  Anesthesiology       Date:  1996-05       Impact factor: 7.892

Review 5.  The neuroleptics as adjuvant analgesics.

Authors:  R B Patt; G Proper; S Reddy
Journal:  J Pain Symptom Manage       Date:  1994-10       Impact factor: 3.612

6.  Individual variability in the response to different opioids: report of five cases.

Authors:  Bradley S Galer; Nessa Coyle; Gavril W Pasternak; Russell K Portenoy
Journal:  Pain       Date:  1992-04       Impact factor: 6.961

Review 7.  Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy.

Authors:  J R Crossen; D Garwood; E Glatstein; E A Neuwelt
Journal:  J Clin Oncol       Date:  1994-03       Impact factor: 44.544

8.  Subcutaneous ketorolac--a new development in pain control.

Authors:  N Blackwell; L Bangham; M Hughes; D Melzack; I Trotman
Journal:  Palliat Med       Date:  1993       Impact factor: 4.762

9.  [The efficacy of intravenous lidocaine on various types of neuropathic pain].

Authors:  T Nagaro; C Shimizu; H Inoue; T Fujitani; N Adachi; K Amakawa; S Kimura; T Arai; T Watanabe; S Oka
Journal:  Masui       Date:  1995-06

Review 10.  Pharmacological treatment of cancer pain: alternative routes of opioid administration.

Authors:  C Ripamonti; E Zecca; F De Conno
Journal:  Tumori       Date:  1998 May-Jun
View more
  2 in total

Review 1.  Regional pain syndromes in cancer patients.

Authors:  H A Zekry; E Bruera
Journal:  Curr Rev Pain       Date:  2000

2.  Radiofrequency ablation for cancer-associated pain.

Authors:  Jay W Patti; Ziv Neeman; Bradford J Wood
Journal:  J Pain       Date:  2002-12       Impact factor: 5.820

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.